Medavail Holdings Inc Revenue Growth Rates (MDVL), Current and Historic Growth - CSIMarket
CSIMarket
 


Medavail Holdings Inc   (NASDAQ: MDVL)
 

MDVL's Revenue Growth by Quarter and Year

Medavail Holdings Inc 's Revenue results by quarter and year




MDVL Revenue (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
4th Quarter December -
3rd Quarter September -
2nd Quarter June 0.41
1st Quarter March 0.62
FY 1.03

MDVLs Annual Revenue
Medavail Holdings Inc 's Revenue in the fiscal year 2022 $ 43.11 millions
Medavail Holdings Inc 's Revenue in the fiscal year 2021 $ 22.13 millions
Medavail Holdings Inc 's Revenue in the fiscal year 2020 $ 13.97 millions
Medavail Holdings Inc 's Revenue in the fiscal year 2019 $ 1.03 millions
Medavail Holdings Inc 's Revenue in the fiscal year 2018 $ 0.36 millions




MDVL Revenue second quarter 2023 Y/Y Growth Comment
Medavail Holdings Inc reported fall in Revenue in the second quarter 2023 by -25% to $ 0.41 millions, from the same quarter in 2022.
The drop in the second quarter 2023 Medavail Holdings Inc 's Revenue compares unfavorably to the Company's average Revenue doubling of 368.58%.

Looking into second quarter 2023 results within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Revenue growth. While Medavail Holdings Inc ' s Revenue drop of -25% ranks overall at the positon no. 4102 in the second quarter 2023.




MDVL Revenue ( Y/Y Growth %) 2023
2022 2021 2020
4th Quarter December - 55.91 % -43.39 % 3284.21 %
3rd Quarter September - 97.93 % -19.02 % 1942.86 %
2nd Quarter June -25 % -89.26 % 117.75 % 1440 %
1st Quarter March 129.63 % -93.3 % 185.82 % 840 %
FY   - 6.73 % -6.74 % -

Financial Statements
Medavail Holdings Inc 's second quarter 2023 Revenue $ 0.41 millions MDVL's Income Statement
Medavail Holdings Inc 's second quarter 2022 Revenue $ 0.54 millions Quarterly MDVL's Income Statement


MDVL Revenue (Quarter on Quarter Growth %)

2023
2022 2021 2020
4th Quarter December - -0.96 % 25.73 % 79.86 %
3rd Quarter September - 2022.22 % 15.11 % 209.52 %
2nd Quarter June -34.68 % 100 % 24.81 % 63.83 %
1st Quarter March -94.54 % -96.29 % -68.66 % 271.05 %
FY (Year on Year)   - 6.73 % -6.74 % -




Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #205
Overall #4102

Revenue Y/Y Growth Statistics
High Average Low
3294.2 % 368.58 % -99.61 %
(Sep 30 2021)   (Sep. 30, 2015)
Revenue second quarter 2023 Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #205
Overall #4102
Revenue Y/Y Growth Statistics
High Average Low
3294.2 % 368.58 % -99.61 %
(Sep 30 2021)   (Sep. 30, 2015)

Revenue by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Medavail Holdings Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2552.37 % 140.91 % -94.54 %
(Dec 31 2020)  


MDVL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Medavail Holdings Inc disclosed fall in Revenue from the first quarter by -34.68% to $ 0.41 millions, from $ 0.62 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2023 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.

Within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Medavail Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3902.


Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #194
Overall #3902
Revenue Q/Q Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry #15
Retail Sector #194
Overall #3902
Revenue Q/Q Growth Statistics
High Average Low
2552.37 % 140.91 % -94.54 %
(Dec 31 2020)  


MDVL's II. Quarter Q/Q Revenue Comment
In the II. Quarter 2023 Medavail Holdings Inc disclosed fall in Revenue from the first quarter by -34.68% to $ 0.41 millions, from $ 0.62 millions achived in the previous reporting period.

Although periodic circumstance commonly energize II. Quarter 2023 Revenue, this plainly could not be substantial to rescue Pharmacy Services & Retail Drugstore's company achievement, Most analysts pointed out.

Within Pharmacy Services & Retail Drugstore industry 14 other companies have achieved higher Revenue quarter on quarter growth. While Medavail Holdings Inc 's Revenue growth quarter on quarter, overall rank is 3902.


Medavail Holdings Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
Cumulative Revenue 12 Months Ending $ 23.84 $ 23.97 $ 23.62 $ 19.55 $ 13.88
Y / Y Revenue Growth (TTM) 71.73 % 30.53 % 6.73 % -29.46 % -52.25 %
Year on Year Revenue Growth Overall Ranking # 494 # 408 # 409 # 653 # 665
Seqeuential Revenue Change (TTM) -0.58 % 1.5 % 20.82 % 40.84 % -24.43 %
Seq. Revenue Growth (TTM) Overall Ranking # 948 # 972 # 3162 # 354 # 356


Cumulative Revenue growth Comment
Although Medavail Holdings Inc 's Annual Revenue growth year on year were below company's average 212.28% , Revenue announced in the Jun 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 71.73% year on year, from 30.53% in Mar 31 2023. And, Medavail Holdings Inc had the highest Revenue growth, in Pharmacy Services & Retail Drugstore industry.

Among companies within the Retail sector 13 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 408 to 494.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 1
Retail Sector # 14
Overall # 494

Revenue TTM Y/Y Growth Statistics
High Average Low
1768.71 %
212.28 %
-97.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 27
S&P 500 # 948
Cumulative Revenue growth Comment
Although Medavail Holdings Inc 's Annual Revenue growth year on year were below company's average 212.28% , Revenue announced in the Jun 30 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 71.73% year on year, from 30.53% in Mar 31 2023. And, Medavail Holdings Inc had the highest Revenue growth, in Pharmacy Services & Retail Drugstore industry.

Among companies within the Retail sector 13 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 408 to 494.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Pharmacy Services & Retail Drugstore Industry # 1
Retail Sector # 14
Overall # 494

Revenue TTM Y/Y Growth Statistics
High Average Low
1768.71 %
212.28 %
-97.46 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 27
S&P 500 # 948




Other Revenue Growth
Pharmacy Services & Retail Drugstore Industry Revenue Growth Trends and Statistics
Retail Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
MDVL's Revenue Growth Ratio versus Pharmacy Services & Retail Drugstore Industry, Retail Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Jun 30 2023 within Retail SectorY/Y Change %Revenue for the quarter ending Jun 30 2023
Gold com Inc -0.91%$ -0.909 millions
Sunstock Inc -1.16%$ -1.162 millions
Scansource Inc -1.37%$ -1.374 millions
Ingles Markets Incorporated-1.67%$ -1.666 millions
Hf Foods Group Inc -2.66%$ -2.662 millions
Arko Corp -2.80%$ -2.800 millions
Sally Beauty Holdings Inc -3.20%$ -3.199 millions
Wayfair inc -3.44%$ -3.441 millions
Domino s Pizza Inc -3.81%$ -3.807 millions
Asbury Automotive Group Inc -5.26%$ -5.258 millions
Revolve Group Inc -5.63%$ -5.628 millions
Herbalife Ltd -5.65%$ -5.651 millions
Cosmos Health Inc -6.40%$ -6.398 millions
Monro Inc -6.47%$ -6.473 millions
Qvc inc -7.02%$ -7.023 millions
Suburban Propane Partners Lp-7.23%$ -7.227 millions
Cdw Corp-8.46%$ -8.456 millions
Bark Inc -8.47%$ -8.474 millions
The Alkaline Water Company Inc -8.49%$ -8.487 millions
Pool Corporation-9.65%$ -9.653 millions
Samsara Luggage Inc -9.82%$ -9.821 millions
Qvc Group Inc -10.29%$ -10.295 millions
Nu Skin Enterprises Inc -10.77%$ -10.766 millions
Growgeneration Corp -11.19%$ -11.191 millions
Pc Connection Inc -11.46%$ -11.462 millions
Camping World Holdings Inc -12.35%$ -12.354 millions
Insight Enterprises Inc -14.35%$ -14.353 millions
Blue Apron Holdings Inc -14.49%$ -14.495 millions
A k a Brands Holding Corp -14.59%$ -14.586 millions
Party City Holdco Inc -14.72%$ -14.723 millions


About Medavail Holdings Inc Revenue Growth Rates (MDVL), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Medavail Holdings Inc (CIK 1402479).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001402479-23-000087
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Medavail Holdings Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.